Section 56
Chapter 55,818

Small compound 6-O-angeloylplenolin induces caspase-dependent apoptosis in human multiple myeloma cells

Liu, Y.; Dong, Y.; Zhang, B.; Cheng, Y.-X.

Oncology Letters 6(2): 556-558


ISSN/ISBN: 1792-1074
PMID: 24137368
DOI: 10.3892/ol.2013.1370
Accession: 055817367

Download citation:  

6-O-angeloylplenolin (6-OAP) is a sesquiterpene lactone agent that has been previously demonstrated to inhibit the growth of multiple myeloma (MM) cells through mitotic arrest with accumulated cyclin B1. In the present study, the levels of apoptosis were analyzed in dexamethasone-sensitive (MM.1S), dexamethasone-resistant (U266) and chemotherapy-sensitive (RPMI 8226) myeloma cell lines. Enhanced apoptosis was identified following a 48-h incubation with 6-OAP (0-10 μM) that induced a dose-dependent decrease in pro-casp-3 and the cleavage of its substrate, anti-poly (ADP-ribose) polymerase (PARP). In addition, time-dependent cleavage of PARP was also detected in U266 and MM.1S cells. The mechanism of 6-OAP cytotoxicity in all cell lines was associated with the induction of apoptosis with the presence of cleaved caspase-3 and PARP. In conclusion, 6-OAP-induced apoptosis is caspase-dependent. These observations are likely to provide a framework for future studies of 6-OAP therapy in MM.

PDF emailed within 0-6 h: $19.90